Intuitive Surgical, Inc. $ISRG Shares Sold by Bender Robert & Associates

Key Points

• Bender Robert & Associates has reduced its holdings in Intuitive Surgical, Inc. by 2.2%, maintaining 73,397 shares, which represents 8.9% of their portfolio.
• Analysts have varied opinions on Intuitive Surgical, with a consensus rating of "Moderate Buy" and a recent average price target of $589.43.
• Insider Gary S. Guthart sold 29,360 shares at an average price of $472.49, significantly reducing his stock ownership by 59.69%.

Bender Robert & Associates lessened its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,397 shares of the medical equipment provider's stock after selling 1,646 shares during the period. Intuitive Surgical makes up 8.9% of Bender Robert & Associates' portfolio, making the stock its 3rd biggest position. Bender Robert & Associates' holdings in Intuitive Surgical were worth $39,885,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Chilton Capital Management LLC grew its stake in Intuitive Surgical by 614.3% in the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock valued at $25,000 after purchasing an additional 43 shares in the last quarter. Elite Financial Inc. acquired a new stake in shares of Intuitive Surgical in the first quarter valued at approximately $26,000. LFA Lugano Financial Advisors SA bought a new position in Intuitive Surgical in the 1st quarter valued at about $30,000. TD Capital Management LLC raised its holdings in shares of Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after buying an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new position in Intuitive Surgical in the 1st quarter valued at approximately $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Evercore ISI lowered their price objective on Intuitive Surgical from $535.00 to $450.00 and set an "in-line" rating for the company in a research report on Tuesday. Weiss Ratings reiterated a "hold (c+)" rating on shares of Intuitive Surgical in a report on Wednesday. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Wall Street Zen raised shares of Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Saturday, October 4th. Finally, Royal Bank Of Canada reissued an "outperform" rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Fourteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and an average price target of $589.43.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction that occurred on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction dated Friday, July 25th. The shares were sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company's stock.

Intuitive Surgical Stock Down 1.0%

Intuitive Surgical stock opened at $443.76 on Friday. The business has a 50-day simple moving average of $459.75 and a 200 day simple moving average of $498.61. The stock has a market cap of $159.08 billion, a price-to-earnings ratio of 61.89, a PEG ratio of 4.71 and a beta of 1.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business's quarterly revenue was up 21.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.78 EPS. On average, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.